FDCA And Liability For State Failure-To-Warn Claims

Law360, New York (January 25, 2010, 11:43 AM ET) -- Federal law requires pharmaceutical manufacturers to obtain approval for drug products from the U.S. Food and Drug Administration prior to marketing. See Food, Drug and Cosmetic Act (“FDCA”), 21 U.S.C. § 301 et seq.

Pursuant to the FDCA, a manufacturer must show that the product is safe and effective for use under the conditions prescribed, recommended or suggested in the proposed labeling. 21 U.S.C. § 355, FDCA 52 Stat. 1040. Likewise, FDA approval for the labeling on pharmaceutical products must be obtained prior to marketing. Id....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles